APA (7th ed.) Citation

Jinhu Liu, Weiwei Mu, Tong Gao, Yuxiao Fang, Na Zhang, & Yongjun Liu. (2023). CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma. MDPI AG.

Chicago Style (17th ed.) Citation

Jinhu Liu, Weiwei Mu, Tong Gao, Yuxiao Fang, Na Zhang, and Yongjun Liu. CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma. MDPI AG, 2023.

MLA (9th ed.) Citation

Jinhu Liu, et al. CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma. MDPI AG, 2023.